24 results on '"Bjermer, L"'
Search Results
2. Analysis of a Composite Endpoint of Exacerbation and Early Study Treatment Withdrawal in Symptomatic Patients with COPD Free of Inhaled Corticosteroids: A Post Hoc Analysis of the EMAX Trial
- Author
-
Kerwin, E.M., primary, Maltais, F., additional, Boucot, I., additional, Naya, I., additional, Bjermer, L., additional, Jones, P., additional, Tombs, L., additional, Lipson, D.A., additional, Compton, C., additional, and Vogelmeier, C., additional
- Published
- 2020
- Full Text
- View/download PDF
3. Improvements in COPD Symptoms with Umeclidinium/Vilanterol Analyzed by Baseline CAT Score: A Post Hoc Analysis of the EMAX Trial
- Author
-
Vogelmeier, C., primary, Boucot, I., additional, Kerwin, E.M., additional, Bjermer, L., additional, Jones, P., additional, Naya, I., additional, Tombs, L., additional, Compton, C., additional, Lipson, D.A., additional, and Maltais, F., additional
- Published
- 2020
- Full Text
- View/download PDF
4. Predicting Improvements in COPD with Clinically Important Improvements in Patient-Reported Outcomes: A Post Hoc Analysis of the EMAX Trial
- Author
-
Vogelmeier, C., primary, Kerwin, E.M., additional, Naya, I., additional, Tombs, L., additional, Bjermer, L., additional, Maltais, F., additional, Jones, P., additional, Lipson, D.A., additional, Compton, C., additional, and Boucot, I., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Expression of Different VEGF Isoforms and Receptors in Primary Distal Lung Fibroblasts and Lung Explants from Patients with COPD
- Author
-
Boger, M., primary, Müller, C., additional, Sohal, S.S., additional, Tufvesson, E., additional, Hallgren, O., additional, Zhou, X.-H., additional, Bjermer, L., additional, Westergren-Thorsson, G., additional, Schmidt, M., additional, and Larsson Callerfelt, A.-K., additional
- Published
- 2019
- Full Text
- View/download PDF
6. Self-Administration of Mepolizumab Liquid Using a Single-Use Prefilled Syringe
- Author
-
Bradford, E.S., primary, Bernstein, D., additional, Bjermer, L., additional, Follows, R., additional, Bentley, J.H., additional, Pouliquen, I., additional, and Bel, E.H., additional
- Published
- 2019
- Full Text
- View/download PDF
7. Expression of Muscarinic M5Receptors on Pulmonary Neuroendocrine Cells: Implications in COPD?.
- Author
-
Mori, M, primary, Andersson, C, additional, Egesten, A, additional, Bjermer, L, additional, Lofdahl, CG, additional, and Erjefalt, JS, additional
- Published
- 2009
- Full Text
- View/download PDF
8. Combination of Budesonide and Formoterol Decreases TGFβ1-Induced Procollagen I Synthesis in Bronchial Biopsy Fibroblasts from Mild Asthmatic Subjects without Affecting Fibroblast Metalloproteolytic Activity.
- Author
-
Todorova, L, primary, Bjermer, L, additional, Miller-Larsson, A, additional, and Westergren-Thorsson, G, additional
- Published
- 2009
- Full Text
- View/download PDF
9. Interleukin-33, a Novel “Alarmin” at Mucosal Surfaces, Is Up-Regulated in COPD.
- Author
-
Andersson, CK, primary, Mori, M, additional, Humbles, AA, additional, Kolbeck, R, additional, Coyle, AJ, additional, Lofdahl, CG, additional, Bjermer, L, additional, and Erjefalt, JS, additional
- Published
- 2009
- Full Text
- View/download PDF
10. Dramatically Altered Mast Cell Populations Infiltrate the Lung in Patients with Severe COPD.
- Author
-
Andersson, CK, primary, Mori, M, additional, Bjermer, L, additional, Lofdahl, CG, additional, and Erjefalt, JS, additional
- Published
- 2009
- Full Text
- View/download PDF
11. Altered Fibroblast Proteoglycan Production in COPD Influence Airway Obstruction?.
- Author
-
Hallgren, O, primary, Nihlberg, K, additional, Bjermer, L, additional, Dahlback, M, additional, Eriksson, L, additional, Lofdahl, C, additional, and Westergren-Thorsson, G, additional
- Published
- 2009
- Full Text
- View/download PDF
12. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.
- Author
-
Andersson CK, Mori M, Bjermer L, Löfdahl CG, and Erjefält JS
- Abstract
Rationale: Mast cells have important roles in innate immunity and tissue remodeling but have remained poorly studied in inflammatory airway diseases like chronic obstructive pulmonary disease (COPD). Objectives: To perform a detailed histological characterization of human lung mast cell populations at different severities of COPD, comparing with smoking and never-smoking control subjects. Methods: Mast cells were analyzed in lung tissues from patients with mild to very severe COPD, GOLD I-IV (n = 25, 10 of whom were treated with corticosteroids). Never-smokers and smokers served as controls. The density, morphology, and molecular characteristics of mucosal and connective tissue mast cells (MC(T) and MC(TC), respectively) were analyzed in several lung regions. Measurements and Main Results: In all compartments of COPD lungs, especially at severe stages, the MC(TC) population increased in density, whereas the MC(T) population decreased. The net result was a reduction in total mast cell density. This phenomenon was paralleled by increased numbers of luminal mast cells, whereas the numbers of terminal transferase dUTP nick end labeling (TUNEL)(+) apoptotic mast cells remained unchanged. In COPD lungs, the MC(T) and MC(TC) populations showed alterations in morphology and expression of CD88 (C5a-R), transforming growth factor (TGF)-beta, and renin. Statistically significant correlations were found between several COPD-related mast cell alterations and lung function parameters. Conclusions: As COPD progresses to its severe stages, the mast cell populations in the lung undergo changes in density, distribution, and molecular expression. In COPD lungs, these novel histopathological features were found to be correlated to lung function and they may thus have clinical consequences. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
13. A Mast Cell Secretogogue, Compound 48/80, Prevents the Accumulation of Hyaluronan in Lung Tissue Injured by Ionizing Irradiation
- Author
-
Nilsson, K., primary, Bjermer, L., additional, Hellström, S., additional, Henriksson, R., additional, and Hällgren, R., additional
- Published
- 1990
- Full Text
- View/download PDF
14. Impaired Differentiation of Chronic Obstructive Pulmonary Disease Bronchial Epithelial Cells Grown on Bronchial Scaffolds.
- Author
-
Hedström U, Öberg L, Vaarala O, Dellgren G, Silverborn M, Bjermer L, Westergren-Thorsson G, Hallgren O, and Zhou X
- Subjects
- Epithelial Cells pathology, Female, Humans, Male, Pulmonary Disease, Chronic Obstructive pathology, Bronchi chemistry, Cell Differentiation, Epithelial Cells metabolism, Extracellular Matrix chemistry, Pulmonary Disease, Chronic Obstructive metabolism, Tissue Scaffolds chemistry
- Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by airway inflammation, small airway remodeling, and emphysema. Airway remodeling in patients with COPD involves both the airway epithelium and the subepithelial extracellular matrix (ECM). However, it is currently unknown how epithelial remodeling in COPD airways depends on the relative influence from inherent defects in the epithelial cells and alterations in the ECM. To address this, we analyzed global gene expression in COPD human bronchial epithelial cells (HBEC) and normal HBEC after repopulation on decellularized bronchial scaffolds derived from patients with COPD or donors without COPD. COPD HBEC grown on bronchial scaffolds showed an impaired ability to initiate ciliated-cell differentiation, which was evident on all scaffolds regardless of their origin. In addition, although normal HBEC were less affected by the disease state of the bronchial scaffolds, COPD HBEC showed a gene expression pattern indicating increased proliferation and a retained basal-cell phenotype when grown on COPD bronchial scaffolds compared with normal bronchial scaffolds. By using mass spectrometry, we identified 13 matrisome proteins as being differentially abundant between COPD bronchial scaffolds and normal bronchial scaffolds. These observations are consistent with COPD pathology and suggest that both epithelial cells and the ECM contribute to epithelial-cell remodeling in COPD airways.
- Published
- 2021
- Full Text
- View/download PDF
15. Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary Disease.
- Author
-
Wijk SC, Prabhala P, Michaliková B, Sommarin M, Doyle A, Lang S, Kanzenbach K, Tufvesson E, Lindstedt S, Leigh ND, Karlsson G, Bjermer L, Westergren-Thorsson G, and Magnusson M
- Subjects
- Antigens, Differentiation metabolism, Cells, Cultured, Epithelial Cells pathology, Humans, Keratin-14 metabolism, Lung pathology, Molecular Chaperones metabolism, Nerve Tissue Proteins metabolism, Pulmonary Disease, Chronic Obstructive pathology, Receptors, Nerve Growth Factor metabolism, Respiratory Mucosa pathology, Epithelial Cells metabolism, Lung metabolism, Pulmonary Disease, Chronic Obstructive metabolism, Respiratory Mucosa metabolism
- Abstract
Airway basal cells are crucial for regeneration of the human lung airway epithelium and are believed to be important contributors to chronic obstructive pulmonary disease (COPD) and other lung disorders. To reveal how basal cells contribute to disease and to discover novel therapeutic targets, these basal cells need to be further characterized. In this study, we optimized a flow cytometry-based cell sorting protocol for primary human airway basal cells dependent on cell size and NGFR (nerve-growth factor receptor) expression. The basal cell population was found to be molecularly and functionally heterogeneous, in contrast to cultured basal cells. In addition, significant differences were found, such as KRT14 expression exclusively existing in cultured cells. Also, colony-forming capacity was significantly increased in cultured cells showing a clonal enrichment in vitro . Next, by single-cell RNA sequencing on primary basal cells from healthy donors and patients with Global Initiative for Chronic Obstructive Lung Disease stage IV COPD, the gene expression revealed a continuum ranging from healthy basal cell signatures to diseased basal cell phenotypes. We identified several upregulated genes that may indicate COPD, such as stress response-related genes GADD45B and AHSA1 , together with with genes involved in the response to hypoxia, such as CITED2 and SOD1 . Taken together, the presence of healthy basal cells in stage IV COPD demonstrates the potential for regeneration through the discovery of novel therapeutic targets. In addition, we show the importance of studying primary basal cells when investigating disease mechanisms as well as for developing future cell-based therapies in the human lung.
- Published
- 2021
- Full Text
- View/download PDF
16. Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
- Author
-
Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D'Urzo AD, and Roche N
- Subjects
- Aged, Aged, 80 and over, Cross-Sectional Studies, Databases, Factual, Female, Forced Expiratory Volume, Humans, Male, Middle Aged, Prevalence, Primary Health Care, Spirometry, United Kingdom epidemiology, Vital Capacity, Asthma complications, Asthma physiopathology, Pulmonary Disease, Chronic Obstructive complications, Pulmonary Disease, Chronic Obstructive physiopathology
- Abstract
Rationale: Adults may exhibit characteristics of both asthma and chronic obstructive pulmonary disease (COPD), a situation recently described as asthma-COPD overlap (ACO). There is a paucity of information about ACO in primary care. Objectives: To estimate the prevalence and describe characteristics of individuals with ACO in primary care practices among patients currently diagnosed with asthma, COPD, or both; and to compare the prevalence and characteristics of ACO among the three source populations. Methods: The Respiratory Effectiveness Group conducted a cross-sectional study of individuals ≥40 years old and with ≥2 outpatient primary care visits over a 2-year period in the UK Optimum Patient Care Research Database. Patients were classified into one of three source populations based on diagnostic codes: 1 ) COPD only, 2 ) both asthma and COPD, or 3 ) asthma only. ACO was defined as the presence of all of the following 1 ) age ≥40 years, 2 ) current or former smoking, 3) post-bronchodilator airflow limitation (forced expiratory volume in 1 second/forced vital capacity <0.7), and 4 ) ≥12% and ≥200 ml reversibility in post-bronchodilator forced expiratory volume in 1 second. Results: Among 2,165 individuals (1,015 COPD only, 395 with both asthma and COPD, and 755 asthma only), the overall prevalence of ACO was 20% (95% confidence interval, 18-23%). Patients with ACO had a mean age of 70 years (standard deviation, 11 yr), 60% were men, 73% were former smokers (the rest were current smokers), and 66% were overweight or obese. Comorbid conditions were common in patients with ACO, including diabetes (53%), cardiovascular disease (36%), hypertension (30%), eczema (23%), and rhinitis (21%). The prevalence of ACO was higher in patients with a diagnosis of both asthma and COPD (32%) compared with a diagnosis of COPD only (20%; P < 0.001) or asthma only (14%; P < 0.001). Demographic and clinical characteristics of ACO varied across these three source populations. Conclusions: One in five individuals with a diagnosis of COPD, asthma, or both asthma and COPD in primary care settings have ACO based on the Respiratory Effectiveness Group ACO Working group criteria. The prevalence and characteristics of patients with ACO varies across the three source populations.
- Published
- 2019
- Full Text
- View/download PDF
17. IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
- Author
-
Roos AB, Sandén C, Mori M, Bjermer L, Stampfli MR, and Erjefält JS
- Subjects
- Aged, Animals, Chemokine CXCL12 metabolism, Disease Models, Animal, Disease Progression, Female, Humans, Male, Mice, Mice, Inbred C57BL, Middle Aged, Interleukin-17 immunology, Lung pathology, Lymphoid Tissue metabolism, Lymphoid Tissue pathology, Pulmonary Disease, Chronic Obstructive immunology, Pulmonary Disease, Chronic Obstructive pathology, Smoking adverse effects
- Abstract
Rationale: End-stage chronic obstructive pulmonary disease (COPD) is associated with an accumulation of pulmonary lymphoid follicles. IL-17A is implicated in COPD and pulmonary lymphoid neogenesis in response to microbial stimuli. We hypothesized that IL-17A is increased in peripheral lung tissue during end-stage COPD and also directly contributes to cigarette smoke-induced lymphoid neogenesis., Objectives: To characterize the tissue expression and functional role of IL-17A in end-stage COPD., Methods: Automated immune detection of IL-17A and IL-17F was performed in lung tissue specimens collected from patients with Global Initiative for Chronic Obstructive Lung Disease stage I-IV COPD, and smoking and never-smoking control subjects. In parallel, Il17a(-/-) mice and wild-type control animals were exposed to cigarette smoke for 24 weeks, and pulmonary lymphoid neogenesis was assessed., Measurements and Main Results: Tissue expression of IL-17A and IL-17F was increased in COPD and correlated with lung function decline. IL-17A was significantly elevated in severe to very severe COPD (Global Initiative for Chronic Obstructive Lung Disease III/IV) compared with both smokers and never-smokers without COPD. Although CD3(+) T cells expressed IL-17A in very severe COPD, most IL-17A(+) cells were identified as tryptase-positive mast cells. Attenuated lymphoid neogenesis and reduced expression of the B-cell attracting chemokine C-X-C motif ligand (CXCL) 12 was observed in cigarette smoke-exposed Il17a(-/-) mice. CXCL12 was also highly expressed in lymphoid follicles in COPD lungs, and the pulmonary expression was significantly elevated in end-stage COPD., Conclusions: IL-17A in the peripheral lung of patients with severe to very severe COPD may contribute to disease progression and development of lymphoid follicles via activation of CXCL12.
- Published
- 2015
- Full Text
- View/download PDF
18. Marked epithelial cell pathology and leukocyte paucity in persistently symptomatic severe asthma.
- Author
-
Bergqvist A, Andersson CK, Hoffmann HJ, Mori M, Shikhagaie M, Krohn IK, Dahl R, Bjermer L, and Erjefält JS
- Subjects
- Asthma drug therapy, Asthma immunology, Biopsy, Case-Control Studies, Female, Humans, Leukocyte Count, Male, Middle Aged, Respiratory Mucosa immunology, Severity of Illness Index, Treatment Outcome, Anti-Inflammatory Agents therapeutic use, Asthma pathology, Drug Resistance, Leukocytes pathology, Prednisolone therapeutic use, Respiratory Mucosa pathology
- Published
- 2013
- Full Text
- View/download PDF
19. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.
- Author
-
Kearley J, Erjefalt JS, Andersson C, Benjamin E, Jones CP, Robichaud A, Pegorier S, Brewah Y, Burwell TJ, Bjermer L, Kiener PA, Kolbeck R, Lloyd CM, Coyle AJ, and Humbles AA
- Subjects
- Allergens administration & dosage, Analysis of Variance, Animals, Asthma metabolism, Biomarkers metabolism, Biopsy, Needle, Cytokines immunology, Cytokines metabolism, Disease Models, Animal, Female, Humans, Mast Cells metabolism, Mice, Mice, Inbred BALB C, Ovalbumin pharmacology, RNA, Messenger analysis, Random Allocation, Respiratory Function Tests, Statistics, Nonparametric, Allergens immunology, Asthma immunology, Bronchoalveolar Lavage Fluid cytology, Interleukin-9 immunology, Lung immunology, Lung pathology, Mast Cells immunology
- Abstract
Rationale: IL-9 is a pleiotropic cytokine that has multiple effects on structural as well as numerous hematopoietic cells, which are central to the pathogenesis of asthma., Objectives: The contribution of IL-9 to asthma pathogenesis has thus far been unclear, due to conflicting reports in the literature. These earlier studies focused on the role of IL-9 in acute inflammatory models; here we have investigated the effects of IL-9 blockade during chronic allergic inflammation., Methods: Mice were exposed to either prolonged ovalbumin or house dust mite allergen challenge to induce chronic inflammation and airway remodeling., Measurements and Main Results: We found that IL-9 governs allergen-induced mast cell (MC) numbers in the lung and has pronounced effects on chronic allergic inflammation. Anti-IL-9 antibody-treated mice were protected from airway remodeling with a concomitant reduction in mature MC numbers and activation, in addition to decreased expression of the profibrotic mediators transforming growth factor-β1, vascular endothelial growth factor, and fibroblast growth factor-2 in the lung. Airway remodeling was associated with impaired lung function in the peripheral airways and this was reversed by IL-9 neutralization. In human asthmatic lung tissue, we identified MCs as the main IL-9 receptor expressing population and found them to be sources of vascular endothelial growth factor and fibroblast growth factor-2., Conclusions: Our data suggest an important role for an IL-9-MC axis in the pathology associated with chronic asthma and demonstrate that an impact on this axis could lead to a reduction in chronic inflammation and improved lung function in patients with asthma.
- Published
- 2011
- Full Text
- View/download PDF
20. Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma.
- Author
-
Larsen K, Tufvesson E, Malmström J, Mörgelin M, Wildt M, Andersson A, Lindström A, Malmström A, Löfdahl CG, Marko-Varga G, Bjermer L, and Westergren-Thorsson G
- Subjects
- Adolescent, Adult, Aged, Asthma physiopathology, Biopsy, Needle, Blotting, Western, Bronchial Provocation Tests, Cell Movement, Cells, Cultured, Cohort Studies, Female, Fibroblasts physiology, Humans, Immunohistochemistry, Male, Microscopy, Electron, Middle Aged, Probability, Prognosis, Sensitivity and Specificity, Severity of Illness Index, Asthma pathology, Bronchial Hyperreactivity diagnosis, Bronchoalveolar Lavage Fluid cytology, Fibroblasts pathology
- Abstract
Activated fibroblasts are suggested to be involved in the deposition of extracellular matrix in the formation of peribronchial fibrosis in asthma. We report the novel finding of activated elongated fibroblasts accompanied by elevated numbers of eosinophils in bronchoalveolar lavage fluid from 5 out of 12 patients with mild asthma (= 42%), whereas no fibroblasts were observed in the control subjects without asthma (n = 17). The elongated fibroblasts migrated twice as far when compared with fibroblasts from corresponding bronchial biopsies from the same patients, accompanied by an induced expression of RhoA and Rac1, indicating that the increased expression of these proteins are linked to increased migratory capabilities. Moreover, the elongated fibroblasts had an elevated production of the proteoglycans biglycan, versican, perlecan, and decorin, which correlated to an active cytoplasm in these cells. Differential expression patterns between the two fibroblast groups in motility-regulating proteins, such as cofilin, nuclear chloride ion channel protein, and heat-shock protein 20, were identified by two-dimensional electrophoresis and mass spectrometry. These findings indicate the presence of activated and mobile fibroblasts accompanied by an induced inflammatory response outside the airway epithelium in patients with mild asthma, results that may play a role in formation of airway fibrosis.
- Published
- 2004
- Full Text
- View/download PDF
21. Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma.
- Author
-
Cai Y, Bjermer L, and Halstensen TS
- Subjects
- Adult, Aged, Asthma enzymology, Asthma immunology, Bronchi metabolism, Bronchial Provocation Tests, Eosinophils cytology, Eosinophils metabolism, Female, Glutathione Transferase immunology, Humans, Immunohistochemistry, Male, Mast Cells cytology, Mast Cells metabolism, Middle Aged, Regression Analysis, Aspirin adverse effects, Asthma metabolism, Bronchi cytology, Glutathione Transferase metabolism, Mast Cells enzymology
- Abstract
The increased bronchial production of leukotriene C4 (LTC4) in asthma is assumed to derive from infiltrating eosinophils expressing LTC4-synthase (LTC4S). Multicolor immunohistofluorescence examination of bronchial cryosections from 30 treated, untreated, or bronchial antigen-provoked aspirin-tolerant individuals with asthma and nine control subjects revealed that the dominating LTC4S-expressing cells were mast cells (> 80%), and not eosinophils. Whereas 95% of the mast cells expressed high levels of LTC4S, only 8-27% of the eosinophils expressed low levels. Image analysis revealed a significantly higher LTC4S expression levels in mast cells than in eosinophils. The bronchial mRNA levels for LTC4S did not correlate with the densities of LTC4S-positive eosinophils or mast cells. Treated individuals with asthma with more than 12% reversibility had significantly higher density of LTC4S-positive mast cells than those with less reversibility, and it correlated significantly with reduction in lung function (FEV1-predicted), both before and after salbutamol inhalation. Thus, mucosal mast cells, and not eosinophils, were the dominating LTC4S-containing cells in both untreated and treated aspirin-tolerant asthma. The density of LTC4S-positive mast cells correlated, moreover, with both the reduction in lung function and the degree of reversibility in treated asthma.
- Published
- 2003
- Full Text
- View/download PDF
22. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.
- Author
-
Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, and Laitinen LA
- Subjects
- Adolescent, Adult, Airway Resistance immunology, Asthma, Exercise-Induced immunology, Asthma, Exercise-Induced pathology, Biopsy, Bronchi immunology, Bronchi pathology, Bronchial Hyperreactivity immunology, Bronchial Hyperreactivity pathology, Bronchial Provocation Tests, Eosinophils immunology, Eosinophils pathology, Humans, Leukocyte Count, Macrophages immunology, Macrophages pathology, Male, Mast Cells immunology, Mast Cells pathology, Respiratory Mucosa immunology, Respiratory Mucosa pathology, T-Lymphocytes immunology, T-Lymphocytes pathology, Tenascin metabolism, Asthma, Exercise-Induced diagnosis, Bronchial Hyperreactivity diagnosis, Skiing physiology
- Abstract
Asthma-like symptoms, methacholine hyperresponsiveness, and use of asthma medication are prevalent in elite cross-country skiers. We quantitated mucosal inflammatory cell infiltration and tenascin expression in the subepithelial basement membrane in endobronchial biopsy specimens of the proximal airways from 40 elite, competitive skiers (mean: 17.5; range: 16 to 20 yr) without a diagnosis of asthma, in 12 subjects with mild asthma, and in 12 healthy controls, through immunohistochemistry and indirect immunofluorescence, respectively. All of the subjects were nonsmokers. T-lymphocyte, macrophage, and eosinophil counts were, respectively, greater by 43-fold (p < 0.001), 26-fold (p < 0.001), and twofold (p < 0.001) in skiers, and by 70-fold (p < 0.001), 63-fold (p < 0.001), and eightfold (p < 0.001) in asthmatic subjects than in controls. In skiers, neutrophil counts were more than twofold greater than in asthmatic subjects, and mast cell counts were not significantly different than in controls. Tenascin expression (as measured through the thickness of the tenascin-specific immunoreactivity band in the basement membrane) was increased in skiers (median: 6.7 microm; interquartile range [IQR]: 5.3 to 8.5 microm, p < 0.001) and asthmatic subjects (mean: 8.8 microm; IQR: 7.2 to 10.8 microm, p < 0. 001) compared with controls (mean: 0.8 microm; IQR: 0 to 3.1 microm) and did not correlate with inflammatory cell counts. Inflammatory changes were present irrespective of asthmalike symptoms, hyperresponsiveness, or atopy. Prolonged repeated exposure of the airways to inadequately conditioned air may induce inflammation and remodeling in competitive skiers.
- Published
- 2000
- Full Text
- View/download PDF
23. Lymphoid aggregates in endobronchial biopsies from young elite cross-country skiers.
- Author
-
Sue-Chu M, Karjalainen EM, Altraja A, Laitinen A, Laitinen LA, Naess AB, Larsson L, and Bjermer L
- Subjects
- Adult, Antibodies, Monoclonal, Biopsy, Bronchi metabolism, Bronchoscopy, Female, Humans, Immunohistochemistry, Lymphocytes pathology, Male, Bronchi pathology, Lymphoid Tissue pathology, Skiing physiology
- Abstract
Observation of bronchus-associated lymphoid tissue (BALT) in whole lung specimens from healthy nonsmoking adults has questioned the hypothesis that BALT is not constitutively present in healthy adult human lungs. In our study, we investigated endobronchial biopsies of the second- and third-generation carinae from 44 cross-country ski athletes and 12 healthy control subjects, all nonsmoking young adults. The skiers had a prevalence of respiratory allergy (18%), asthma-like symptoms (59%), beta2 agonist medication (25%), and methacholine bronchial hyperresponsiveness (79%). Biopsy sections were stained by immunohistochemical and hematoxylin-eosin-saffran methods. Lymphoid aggregates of more than 50 cells were identified in 28 (64%) skiers and three (25%) control subjects (p = 0.02). They were small in comparison to those found in rabbits and rats, contained T and B lymphocytes and macrophages, and were seen more frequently in skiers using beta2 agonists (p = 0.04) and with bronchial hyperresponsiveness to methacholine (p = 0.053). The frequency of these aggregates was not significantly different at the two carinal levels (p = 0.6). The aggregates were not associated with a history of respiratory allergy or asthma-like symptoms. These aggregates share some resemblance with what is usually defined as BALT. However, their exact nature and function await further clarification.
- Published
- 1998
- Full Text
- View/download PDF
24. Mast cells and biogenic amines in radiation-induced pulmonary fibrosis.
- Author
-
Aldenborg F, Nilsson K, Jarlshammar B, Bjermer L, and Enerbäck L
- Subjects
- Animals, Cytoplasmic Granules ultrastructure, Lung chemistry, Male, Mast Cells chemistry, Microscopy, Electron, Organelles ultrastructure, Pulmonary Fibrosis etiology, Pulmonary Fibrosis metabolism, Radiation Injuries, Experimental metabolism, Radiation Injuries, Experimental pathology, Rats, Rats, Sprague-Dawley, Skin chemistry, Specific Pathogen-Free Organisms, Histamine analysis, Lung pathology, Mast Cells ultrastructure, Pulmonary Fibrosis pathology, Serotonin analysis
- Abstract
Sprague-Dawley rats were exposed to a single X-ray dose of 30 Gy over the lungs and examined at 1-wk intervals during the following 3 to 8 wk. Mast cells were counted after specific staining with toluidine blue at a low pH and the mast-cell amines, histamine (Hi) and serotonin (5-HT), were measured using high-performance liquid chromatography. Irradiation induced pneumonitis followed by pulmonary mast-cell hyperplasia and progressive fibrosis 4 to 8 wk after irradiation. By week 4, immature-looking mast cells with a few granules started to appear, followed by a gradual increase in mast cells that reached very high levels after 8 wk, up to 40 to 200 times the normal. The pulmonary Hi and 5-HT content increased concomitantly from 6 and 1 micrograms/g to a maximum of 200 and 18 micrograms/g, respectively. These high levels of amine content and mast-cell densities greatly exceed those of any normal tissue. There was a strong correlation between the Hi and 5-HT content in both normal (r = 0.87) and irradiated (r = 0.93) lung tissue, as well as between the mast-cell density and amine content after irradiation (r = 0.86), thereby indicating that both amines derived from mast cells. The Hi/5-HT quotients were much lower in both normal and irradiated lung tissue (5 and 9, respectively) than in other tissues where these amines are stored in mast cells, or in isolated peritoneal mast cells (43). This relatively higher 5-HT content in pulmonary mast cells suggests that this amine performs a specific function in the lung.
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.